AltheaDx Company
%20.jpg)
AltheaDx, Inc. provides molecular diagnostics and PCR-based services. It offers molecular biomarker discovery, assay development, assay validation, and prospective/retrospective clinical trial testing services. The company also provides gene expression and genotyping analysis for pre-clinical and clinical applications. In addition, it offers discovery services, such as microarray analysis, real-time PCR, next-gen sequencing, quantitative PCR, mutation scanning, data analysis, race assay, and therapeutic siRNA; and diagnostic development services.
Founded Date:
2009-01-01
Total Funding:
$76.7M
Investor Type:
For Profit
Employee Number:
101-250
Technology:
Biomarkers
Last Funding Type:
Venture - Series Unknown
Investors Number:
2
Industry:
Biotechnology, Clinical Trials, Genetics, Health Care, Health Diagnostics
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M